591 related articles for article (PubMed ID: 23149705)
21. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
22. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and Management of Cutaneous B-cell Lymphoma.
Pinter-Brown LC
Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
25. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP
Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
28. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
30. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.
Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM
JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous B-cell lymphoma: important diagnostic tools.
Ferenczi K
G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
[TBL] [Abstract][Full Text] [Related]
33. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
34. Classification of primary cutaneous large cell lymphomas.
Willemze R; Beljaards RC; Rijlaarsdam U
Dermatol Clin; 1994 Apr; 12(2):361-73. PubMed ID: 8045048
[TBL] [Abstract][Full Text] [Related]
35. CD30 expression in cutaneous B-cell lymphomas.
Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2023 Aug; 98(8):1326-1332. PubMed ID: 37434388
[TBL] [Abstract][Full Text] [Related]
37. Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type.
Fenot M; Quereux G; Brocard A; Renaut JJ; Dreno B
Eur J Dermatol; 2010; 20(6):753-7. PubMed ID: 20956100
[TBL] [Abstract][Full Text] [Related]
38. Unusual clinicopathological presentation of primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple nodules and widespread garland-like lesions.
Belousova IE; Vanecek T; Skreg SV; Rodionov AN; Samtsov AV; Kazakov DV
Am J Dermatopathol; 2009 Jun; 31(4):370-4. PubMed ID: 19461242
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
[TBL] [Abstract][Full Text] [Related]
40. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
